Treating diseases that cause dementia is becoming more promising. However, individuals with rare or atypical forms—such as Posterior Cortical Atrophy (PCA) syndrome—still face significant challenges. At the University of Colorado School of Medicine, we’ve conducted a series of studies aimed at understanding the early signs and progression of PCA to reduce barriers to clinical trial participation, and we have developed a program to share these insights.
Date: June 23rd, 2025
Time: Webinar 12:00 pm - 12:45 pm or in-person lunch 12-1.
Location: Krugman Conference Hall, Anschutz Medical Campus
Treating diseases that cause dementia is becoming more promising. However, individuals with rare or atypical forms—such as Posterior Cortical Atrophy (PCA) syndrome—still face significant challenges. At the University of Colorado School of Medicine, we’ve conducted a series of studies aimed at understanding the early signs and progression of PCA to reduce barriers to clinical trial participation, and we have developed a program to share these insights.
Date: June 23rd, 2025
Time: Webinar 12:00 pm - 12:45 pm or in-person lunch 12-1.
Location: Krugman Conference Hall, Anschutz Medical Campus